STOCK TITAN

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nephros, Inc. (Nasdaq: NEPH) reported preliminary revenue results for Q4 and full year 2022. Q4 net revenue is projected at $2.6 million, a 6% increase quarter-over-quarter but a 6% decline year-over-year. Full-year revenue stands at $10.0 million, down 2% compared to 2021. Despite challenges, the company saw sequential revenue growth and a record of 1,394 Active Customer Sites. Net cash flow improved, with a negative $500,000 in the second half versus $2.9 million in the first half. Nephros ended Q4 with $3.6 million cash.

Positive
  • Sequential revenue growth of 6% in Q4.
  • Record Active Customer Sites at 1,394.
  • Improved net cash flow of negative $500,000 in H2 2022, up from negative $2.9 million in H1.
Negative
  • Q4 revenue decreased by 6% compared to Q4 2021.
  • Full-year revenue declined by 2% compared to 2021.

Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million;
Active Customer Sites Continue to Climb

SOUTH ORANGE, NJ, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWireNephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the fourth quarter and fiscal year ended December 31, 2022.

Net revenue for the quarter ended December 31, 2022, is expected to be approximately $2.6 million, a 6% quarter-over-quarter increase and a 6% decrease from the quarter ended December 31, 2021. Full-year 2022 net revenue is expected to be approximately $10.0 million, a 2% decrease over 2021.

"Nephros certainly faced some headwinds in 2022, but we ended the year on a strong positive note, with sequential revenue growth, record Active Customer Sites (ACS), and significantly improved net cash flow," said Andy Astor, President and Chief Executive Officer. “Quarter-over-quarter revenue increased 6% in the fourth quarter, ACS increased to a new record of 1,394, and our net cash flow for the second half of the year was approximately negative $500,000, compared to negative $2.9 million in the first half.”

Nephros ended the fourth quarter with approximately $3.6 million in cash on a consolidated basis.

The company will announce its fourth quarter and fiscal 2022 results on Wednesday, March 8, 2023, after market close and host a conference call that same day at 4:30pm ET.

About Nephros

Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.

For more information about Nephros, please visit us at nephros.com.

Forward-Looking Statements

This release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding Nephros’ expected revenue and cash flows for the quarter and year ended December 31, 2022, expected future revenue growth and the timing of such growth, and other statements that are not historical facts, including statements that may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including the impact of the ongoing COVID-19 pandemic, changes in business, Nephros’ ability to further develop its sales organization, inflationary factors and other economic and competitive conditions, the availability of capital when needed, dependence on third-party manufacturers and researchers, and regulatory reforms. These and other risks and uncertainties are detailed in Nephros’ reports filed with the U.S. Securities and Exchange Commission. Nephros does not undertake any responsibility to update the forward-looking statements in this release.

Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Andy Astor, CEO
Nephros, Inc.
(201) 343-5202 x120
andy.astor@nephros.com


FAQ

What were Nephros' revenue results for Q4 2022?

Nephros reported Q4 2022 revenue of approximately $2.6 million, which is a 6% increase from Q3 2022.

How did Nephros perform in terms of revenue for the full year 2022?

Full-year revenue for Nephros in 2022 was approximately $10.0 million, representing a 2% decrease from 2021.

What is the significance of Active Customer Sites for Nephros?

Nephros reached a record of 1,394 Active Customer Sites, which indicates growth in its customer base.

What was Nephros' cash position at the end of Q4 2022?

At the end of Q4 2022, Nephros had approximately $3.6 million in cash.

Nephros Inc.

NASDAQ:NEPH

NEPH Rankings

NEPH Latest News

NEPH Stock Data

15.71M
9.24M
12.75%
40.93%
0.01%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
SOUTH ORANGE